Cervical Cancer (Therapy)

Treatment Complications and Survival Studied

Published in Women's Health Weekly, September 1st, 1997

Stage Ib and IIa cervical cancers are treated equally well by radical surgery or radiotherapy, but there are few data about the survival rates and patterns of complications and recurrences associated with each treatment.

Dr. Fabio Landoni and colleagues, from Milan, Italy, reported the results of a randomized trial of two treatments for early cervical cancer that show that a combination of the two therapies give the worst complications and that menopausal status, age, medical illness, type of cancer, and cervical diameter need to be considered before optimum therapy can be chosen (The Lancet, August 23, 1997, vol 350, no. 9077).

Of 343 women with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1997-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry